NRXPNRX Pharmaceuticals, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 19314
Ticker: NRXP
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-05-25
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: NRXP

Detail

Enriched 2026-08-14 20:47

Market cap: $143,809,411.2
Shares outstanding (class): 36,228,992
Shares outstanding (weighted): 42,800,420
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 29
Location: WILMINGTON, DE
Homepage: https://nrxpharma.com
Description: NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Market cap and share counts drift.

Funds holding this security

8 funds · 8 positions · $3.51M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$1.59M	0.00%	744,532 NS	FIGI
AdvisorShares Psychedelics ETF AdvisorShares Trust	PSIL	$895.6K	4.42%	420,467 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$690.5K	0.00%	324,194 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$140.8K	0.01%	66,109 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$133.4K	0.00%	62,612 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$61.4K	0.00%	28,846 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$9.0K	0.01%	4,246 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	-$5.8K	-0.00%	-2,711 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERNRXP
FIGI_COMPOSITEBBG00JCWDN63
FIGI_SHARE_CLASSBBG00JCWDNX3
CIK0001719406
ISINUS6294442099
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The company is a pharmaceutical preparation firm as indicated by SIC 2834, and the security is common stock.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.